Constipation in cancer patients on morphine

Supportive Care in Cancer

Volumn 16, Issue 5, 2008, Pages 453-459

  Droney, Joanne ^a   Ross, Joy ^b   Gretton, Sophy ^a   Welsh, Ken ^c   Sato, Hiroe ^c   Riley, Julia ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b St Joseph's Hospice   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; Constipation; Laxative dose groups; Laxatives; Morphine

Indexed keywords

BISACODYL; DANTRON; DOCUSATE SODIUM; LACTULOSE; MACROGOL 3350; MORPHINE;

ARTICLE; CANCER DIAGNOSIS; CANCER PAIN; CANCER PATIENT; CONSTIPATION; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

ANALGESICS, OPIOID; COHORT STUDIES; CONSTIPATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LAXATIVES; MALE; MORPHINE; NEOPLASMS; PAIN; PALLIATIVE CARE; TREATMENT OUTCOME;

EID: 41849131852     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0373-1     Document Type: Article

References (32)

1. Bennett M, Cresswell H (2003) Factors influencing constipation in advanced cancer patients: a prospective study of opioid dose, dantron dose and physical functioning. Palliat Med 17:418-422
2. British Medical Association, Royal Pharmaceutical Society of Great Britain (2007) British National Formulary. Bemrose Security Printing, Derby
3. Bruera E, Suarez-Almazor M, Velasco A, Bertolino M, MacDonald SM, Hanson J (1994) The assessment of constipation in terminal cancer patients admitted to a palliative care unit: a retrospective review. J Pain Symptom Manage 9:515-519
4. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V (2001) Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19:2542-2554
5. Fallon MT, Hanks GW (1999) Morphine, constipation and performance status in advanced cancer patients. Palliat Med 13:159-160
6. Gibson RJ, Keefe DM (2006) Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer 14:890-900
7. Grond S, Zech D, Diefenbach C, Bischoff A (1994) Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 9:372-382
8. Herz MJ, Kahan E, Zalevski S, Aframian R, Kuznitz D, Reichman S (1996) Constipation: a different entity for patients and doctors. Fam Pract 13:156-159
9. Holzer P (2004) Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neurosci Lett 361:192-195
10. Kurz A, Sessler DI (2003) Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 63:649-671
11. Mancini I, Bruera E (1998) Constipation in advanced cancer patients. Support Care Cancer 6:356-364
12. Mancini IL, Hanson J, Neumann CM, Bruera ED (2000) Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study. J Palliat Med 3:49-56
13. McMillan SC, Williams FA (1989) Validity and reliability of the Constipation Assessment Scale. Cancer Nurs 12:183-188
14. Miles C, Fellowes D, Goodman M, Wilkinson S (2006) Laxatives for the management of constipation in palliative care patients. Cochrane Database Syst Rev CD003448
15. Pappagallo M (2001) Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 182:11-18
16. Portenoy RK (1987) Constipation in the cancer patient: causes and management. Med Clin North Am 71:303-311
17. Riechelmann RP, Krzyzanowska MK, O'carroll A, Zimmermann C (2007) Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer, 15(12):1407-1412
18. Riley J, Ross JR, Rutter D, Wells AU, Goller K, Du BR, Welsh K (2006) No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Support Care Cancer 14:56-64
19. Ross JR, Rutter D, Welsh K, Joel SP, Goller K, Wells AU, Du BR, Riley J (2005) Clinical response to morphine in cancer patients and genetic variation in candidate genes. Pharmacogenomics J 5:324-336
20. Schug SA, Zech D, Grond S, Jung H, Meuser T, Stobbe B (1992) A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage 7:259-266
21. Schuit KW, Sleijfer DT, Meijler WJ, Otter R, Schakenraad J, van den Bergh FC, Meyboom-de JB (1998) Symptoms and functional status of patients with disseminated cancer visiting outpatient departments. J Pain Symptom Manage 16:290-297
22. Sykes, N (2007) Methods for clinical research in constipation. internet. 21-6-2007. Ref Type: Electronic Citation
23. Sykes NP (1994) Current approaches to the management of constipation. Cancer Surv 21:137-146
24. Sykes NP (1996) A volunteer model for the comparison of laxatives in opioid-related constipation. J Pain Symptom Manage 11:363-369
25. Sykes NP (1998) The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med 12:375-382
26. Sykes NP (2006) The pathogenesis of constipation. J Support Oncol 4:213-218
27. Talley NJ, Jones M, Nuyts G, Dubois D (2003) Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol 98:1107-1111
28. The Royal Marsden (2002) Guidelines for Symptom Control
29. Twycross RG, Harcourt J (1991) The use of laxatives at a palliative care centre. Palliative Medicine 5:27-33
30. Twycross RG, Wilcock A, Charlesworth S, Dickman A (2002) Palliative Care Formulary. Radcliffe Medical Press, London
31. Vainio A, Auvinen A (1996) Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage 12:3-10
32. Vanegas G, Ripamonti C, Sbanotto A, De CF (1998) Side effects of morphine administration in cancer patients. Cancer Nurs 21:289-297